文献速递烧伤瘢痕与激光

烧伤人群长期临床试验招募与保留的挑战:慢性神经症状干预试验的经验教训

Longitudinal Clinical Trial Recruitment and Retention Challenges in the Burn Population: Lessons Learned From a Trial Examining a Novel Intervention for Chronic Neuropathic Symptoms.
PubMed 文献 · J Burn Care Res · 2019-01-01

该平行双盲安慰剂对照随机试验使用经颅直流电刺激治疗烧伤后慢性疼痛和瘙痒,共随机31例受试者。结果显示组间退出率无差异(χ2(1)=0.003,P=.954),总体退出率45.2%,提示烧伤人群长期试验面临招募和依从性挑战。

要点

  • 烧伤后慢性疼痛/瘙痒的长期随机对照试验总体退出率达45.2%
  • 经颅直流电刺激组与假刺激组退出率无显著差异(P=.954)
  • 烧伤人群长期试验需重视招募与依从性管理

核心结论

  • 长期临床试验是评估慢性疼痛和瘙痒等干预措施的关键,但烧伤人群的长期研究常面临招募和依从性挑战。

研究设计与样本

  • 平行双盲、安慰剂对照随机试验,共随机31例受试者进入活性或假经颅直流电刺激组。
  • 试验包括15次经颅直流电刺激访视和7次随访访视。
  • 纳入标准为年龄>18岁、烧伤至少发生在入组前3周、报告中度至重度疼痛和/或瘙痒。

主要发现

  • 组间在年龄、种族、教育程度、基线抑郁或焦虑方面无显著差异。
  • 中位退出时间为第19次访视(假刺激组第16次访视[SE=1.98],活性组第19次访视[SE=1.98])。
  • 组间退出率无差异[χ2(1)=0.003,P=.954]。
  • 假刺激组退出率为46.7%,活性组为43.8%,总体退出率为45.2%。

临床怎么用

  • 在烧伤人群开展长期临床试验时,应预期较高的退出率并制定相应的招募和保留策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long-term trials are key to understanding chronic symptoms such as pain and itch. However, challenges such as high attrition rates and poor recruitment are common when conducting research. The aim of this work was to explore these issues within a long-term randomized control trial using transcranial direct current stimulation to treat pain and itch. This parallel double blinded, placebo-controlled randomized trial was comprised of 15 transcranial direct current stimulation visits and 7 follow-up visits. Participants were over the age of 18, had a burn injury that occurred at least 3 weeks before enrollment, and reported having pain and/or itch that was moderate to severe in intensity. A total of 31 subjects were randomized into either an active or sham transcranial direct current stimulation groups. There were no significant differences between the groups in terms of age, race, education, baseline depression, or anxiety. The median dropout time was at visit 19 (visit 16 [SE = 1.98] for the sham group and visit 19 [SE = 1.98] for the active group). Analysis showed no differences in the dropout rate between groups [χ2(1) = 0.003, P = .954]. The dropout rate was 46.7% for the sham group and 43.8% for the active group. Overall, 45.2% of the subjects dropped out of the trial. Long-term clinical trials are an essential part of evaluating interventions for symptoms such as chronic pain and itch. However, as seen in this trial, long-term studies in the burn population often face recruitment and adherence challenges.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Ohrtman EA, Zaninotto AL, Carvalho S, et al. Longitudinal Clinical Trial Recruitment and Retention Challenges in the Burn Population: Lessons Learned From a Trial Examining a Novel Intervention for Chronic Neuropathic Symptoms. J Burn Care Res. 2019. PMID: 31102438. doi:10.1093/jbcr/irz084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。